Decision making for anti-VEGF inhibitor continuation: dip stick? or urine protein/creatinine ratio? (VERSiON UP study)

Decision making for anti-VEGF inhibitor continuation: dip stick? or urine protein/creatinine ratio? (VERSiON UP study)

Abstract Background Monitoring proteinuria is important for the management of patients with cancer treated with anti-vascular endothelial growth factor (VEGF) or anti-VEGF receptor (VEGFR) inhibitors (VEGF/Ri). Here we investigated the difference between the urine protein/creatinine ratio (UPCR) and...

Full description

Bibliographic Details
Main Authors: Michio Nakamura, Taro Funakoshi, Shigeki Kataoka, Takahiro Horimatsu, Yoshitaka Nishikawa, Takeshi Matsubara, Takuro Mizukami, Tomoyuki Goto, Kenji Tsuchihashi, Eishi Baba, Takehiko Tsumura, Yoshiaki Mihara, Tetsuya Hamaguchi, Motoko Yanagita, Manabu Muto
Format: Article
Language:English
Published: BMC 2022-05-01
Series:BMC Cancer
Subjects:
Anti-vascular endothelial growth factor therapy
Gastrointestinal cancer
Proteinuria
Urine protein/creatinine ratio
Online Access:https://doi.org/10.1186/s12885-022-09611-3

Internet

https://doi.org/10.1186/s12885-022-09611-3

Similar Items